The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $56.55

Today's change+0.60 +1.07%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $56.55

Today's change+0.60 +1.07%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc up (U.S.)$0.60

USANA Health Sciences Inc closed up Friday by (U.S.)$0.60 or 1.07% to (U.S.)$56.55. Over the last five days, shares have lost 3.83% and are down 7.60% for the last year to date. This security has underperformed the S&P 500 by 25.41% during the last year.

Key company metrics

  • Open(U.S.) $55.55
  • Previous close(U.S.) $55.95
  • High(U.S.) $56.95
  • Low(U.S.) $55.55
  • Bid / Ask(U.S.) $53.55 / (U.S.) $58.40
  • YTD % change-7.60%
  • Volume79,925
  • Average volume (10-day)182,938
  • Average volume (1-month)156,127
  • Average volume (3-month)166,786
  • 52-week range(U.S.) $52.55 to (U.S.) $75.00
  • Beta1.11
  • Trailing P/E14.65×
  • P/E 1 year forward14.76×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.86
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.47%

Based on its net profit margin of 9.47%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016
Revenue257255253254
Total other revenue--------
Total revenue257255253254
Gross profit213213207209
Total cost of revenue44434645
Total operating expense225222221218
Selling / general / administrative181180175173
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income32333236
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax33333236
Income after tax23212230
Income tax, total1012106
Net income23212230
Total adjustments to net income--------
Net income before extra. items23212230
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items23212230
Inc. avail. to common incl. extra. items23212230
Diluted net income23212230
Dilution adjustment--------
Diluted weighted average shares25252525
Diluted EPS excluding extraordinary itemsvalue per share0.930.860.871.20
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.930.860.871.20